These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21774813)

  • 1. Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa.
    Togun T; Peterson I; Jaffar S; Oko F; Okomo U; Peterson K; Jaye A
    AIDS Res Ther; 2011 Jul; 8(1):24. PubMed ID: 21774813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Jaye A
    AIDS Res Ther; 2012 Oct; 9(1):28. PubMed ID: 23031736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
    Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
    Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
    Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
    Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
    McGrath N; Lessells RJ; Newell ML
    HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
    Mugglin C; Estill J; Wandeler G; Bender N; Egger M; Gsponer T; Keiser O;
    Trop Med Int Health; 2012 Dec; 17(12):1509-20. PubMed ID: 22994151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa, Oromia region, Ethiopia: a retrospective cohort study.
    Tesfamariam K; Baraki N; Kedir H
    BMC Res Notes; 2016 Dec; 9(1):512. PubMed ID: 27998310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.
    Brinkhof MW; Boulle A; Weigel R; Messou E; Mathers C; Orrell C; Dabis F; Pascoe M; Egger M;
    PLoS Med; 2009 Apr; 6(4):e1000066. PubMed ID: 19399157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.
    Amuron B; Namara G; Birungi J; Nabiryo C; Levin J; Grosskurth H; Coutinho A; Jaffar S
    BMC Public Health; 2009 Aug; 9():290. PubMed ID: 19671185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study.
    Ingle SM; May M; Uebel K; Timmerman V; Kotze E; Bachmann M; Sterne JA; Egger M; Fairall L;
    AIDS; 2010 Nov; 24(17):2717-25. PubMed ID: 20935554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with pre-ART loss-to-follow up in adults in rural KwaZulu-Natal, South Africa: a prospective cohort study.
    Evangeli M; Newell ML; McGrath N
    BMC Public Health; 2016 Apr; 16():358. PubMed ID: 27117271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
    Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
    BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in clinical characteristics and outcomes of Pre-ART care at a large HIV clinic in Nairobi, Kenya: a retrospective cohort study.
    Mecha JO; Kubo EN; Nganga LW; Muiruri PN; Njagi LN; Mutisya IN; Odionyi JJ; Ilovi SC; Wambui M; Githu C; Ngethe R; Obimbo EM; Ngumi ZW
    AIDS Res Ther; 2016; 13():38. PubMed ID: 27895697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda.
    Castelnuovo B; Musaazi J; Musomba R; Ratanshi RP; Kiragga AN
    BMC Infect Dis; 2015 Jul; 15():252. PubMed ID: 26126616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa.
    Leroi C; Balestre E; Messou E; Minga A; Sawadogo A; Drabo J; Maiga M; Zannou M; Seydi M; Dabis F; Jaquet A;
    PLoS One; 2017; 12(1):e0170753. PubMed ID: 28122041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.
    Brinkhof MW; Spycher BD; Yiannoutsos C; Weigel R; Wood R; Messou E; Boulle A; Egger M; Sterne JA;
    PLoS One; 2010 Nov; 5(11):e14149. PubMed ID: 21152392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.